Blood cancer treatment is entering a new era, bringing powerful breakthroughs that offer renewed hope to people living with leukemia, lymphoma, myeloma, and other blood cancers. Cutting-edge targeted ...
Treatment for stage 2 essential thrombocythemia is highly personalized. Not every patient requires medication right away, and ...
In many ways, Zach Montag is a typical suburban Philadelphia 13-year-old. He’s in seventh grade, has been taking karate classes, and likes swimming, ice skating and rock climbing. What sets Zach apart ...
An enduring challenge for the study of human cancer is just how complex it is: how many different ways there are for cancers ...
ABP News on MSN
World Cancer Day 2026: How precision onco-haematology is personalising blood cancer treatment and reducing relapse
By: Dr. Amrit Kaur Kaler For patients diagnosed with blood cancers such as leukemia, lymphoma, and multiple myeloma, the ...
Iberdomide, combined with Darzalex and dexamethasone, improves MRD negativity in relapsed multiple myeloma, showcasing CELMoDs' potential in treatment. Early-stage blood cancer diagnosis and ...
Read full article: San Antonio shelters, businesses brace for impact as back-to-back cold weekends strain resources A San Antonio woman, Marisa Magana, is facing multiple felony charges after a ...
Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found. Working with ...
An international research team with strong participation from DTU has developed a new biotechnological platform that makes it ...
Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results